In continuation to the Exchanges notice no. 20250715-53 dated Tuesday, July 15, 2025, Trading Members are hereby informed that the trading in the equity shares of Asston Pharmaceuticals Limited (Scrip Code: 544445) shall be transferred from Trade for Trade segment (MT Group) to Rolling segment with effect from Wednesday, July 30, 2025. Accordingly, the dealings in the equity shares of the company will be shifted to M Group.